Skip to main content
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.

  • More Medication but Fewer Side Effects

    News in Context: Cholesterol Medication and Parkinson’s

    New study suggests cholesterol-lowering statin medications may decrease risk of Parkinson’s. These findings add to a conflicting area of research.

  • Three people talking at a clinic

    Research Roundup: Studies Need People with and without Parkinson’s to Speed Progress

    In this research roundup blog, we share a range of studies in need of volunteers. Some collect information on health and disease; others test new therapies.

  • ACI-12589 PET images.png

    Breaking News: Critical Advance Announced in Imaging the Living Parkinson’s Brain

    A tracer to visualize alpha-synuclein in the brains of people living with Parkinson’s is one of The Michael J. Fox Foundation’s top research priorities.

  • Trials Testing New Therapies for Parkinson's Symptoms

    What We Fund: $48.8 Million to Advance Novel Therapies and Broader Understanding of Disease  

    In this bimonthly report, The Michael J. Fox Foundation (MJFF) announces 91 grants totaling more than $48.8 million awarded in December and January. These supported projects are driving toward…

  • Picture of a pill

    New Levodopa Pill Hits Pharmacy Shelves

    A new, easy-to-break levodopa pill aims to allow smaller, more precise doses for potentially better symptom control.

  • Study on Rate of Dopamine Loss Emphasizes Need for Biomarkers

    What We Fund Highlight: Replacing Dopamine with Stem Cells and Brain Cells

Close-up portrait

Join the Study that Could Change Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.